Thank you, Mr. Chair.
I thank the witnesses for being here.
Mr. Swedlove, in your opening statement on page 2, you actually say, “...private insurers generally provide Canadians with access to far more drugs than public plans and we allow access to new drugs much more quickly than the public plans.”
Some of the witnesses we heard earlier don't think the same way as you do on that. Do you have any numbers to support that statement?